Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 12, 2016 - Issue 1
Submit an article Journal homepage
4,550
Views
25
CrossRef citations to date
0
Altmetric
Editorials

Interleukin 17-A inhibition in the treatment of psoriasis

Zenas ZN YiuDermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UKView further author information
&
Christopher EM GriffithsDermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UKCorrespondence[email protected]
View further author information
Pages 1-4 | Published online: 11 Nov 2015

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Tessa L Hanley & Zenas ZN Yiu. (2017) Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab. Therapeutics and Clinical Risk Management 13, pages 315-323.
Read now
Anna Balato, Emanuele Scala, Nicola Balato, Giuseppina Caiazzo, Roberta Di Caprio, Giuseppe Monfrecola, Annunziata Raimondo, Serena Lembo & Fabio Ayala. (2017) Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders. Expert Opinion on Biological Therapy 17:11, pages 1363-1374.
Read now
Zenas Z. N. Yiu & Richard B. Warren. (2017) The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasis. Expert Opinion on Investigational Drugs 26:2, pages 243-249.
Read now
Christoforos Vlachos, Georgios Gaitanis, Konstantinos H Katsanos, Dimitrios K Christodoulou, Epameinondas Tsianos & Ioannis D Bassukas. (2016) Psoriasis and inflammatory bowel disease: links and risks. Psoriasis: Targets and Therapy 6, pages 73-92.
Read now

Articles from other publishers (21)

Kristína Gibalová. (2023) Psoriasis and inflammatory bowel disease. Dermatologie pro praxi 17:2, pages 88-90.
Crossref
Ardea Milidrag, Medo Gutić, Ivana Rodić, Ana Pjevač, Tatjana Mladenović, Vesna Miličić & Ana Ravić-Nikolić. (2022) Adverse Effect in Patients with Psoriasis Treated with Interleukin 17A Inhibitor- Secukinumab. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Yike Huang, Chenhui Zhang, Lu Tao, Jiaqing Zhou, Jie Zhu, Kexiang Yan, Ling Han, Qiong Huang, Jinxiu Shi & Zhenghua Zhang. (2020) Updating and identifying three novel variants of the CARD14 gene in Chinese Han patients with psoriasis. Journal of Genetics 99:1.
Crossref
Julia Borowczyk, Claudia Buerger, Neschaat Tadjrischi, Justyna Drukala, Michal Wolnicki, Dawid Wnuk, Ali Modarressi, Wolf-Henning Boehncke & Nicolò Costantino Brembilla. (2020) IL-17E (IL-25) and IL-17A Differentially Affect the Functions of Human Keratinocytes. Journal of Investigative Dermatology 140:7, pages 1379-1389.e2.
Crossref
Ryan Rivera-Oyola, Merav Koschitzky & Mark Lebwohl. (2020) Reply to research letter. Journal of the American Academy of Dermatology.
Crossref
Esther von Stebut, Wolf-Henning Boehncke, Kamran Ghoreschi, Tommaso Gori, Ziya Kaya, Diamant Thaci & Andreas Schäffler. (2020) IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications. Frontiers in Immunology 10.
Crossref
A. Mourad, S. Straube, S. Armijo‐Olivo & R. Gniadecki. (2019) Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta‐analysis. British Journal of Dermatology 181:3, pages 450-458.
Crossref
Amanda Szczepanik, Carlo J. Iasella, John F. McDyer & Christopher R. Ensor. (2019) Cytokine-targeted therapy for the management of solid organ transplant recipients. Human Immunology 80:3, pages 184-190.
Crossref
Eric D. Schadler, Bernhard Ortel & Stephanie L. Mehlis. (2019) Biologics for the primary care physician: Review and treatment of psoriasis. Disease-a-Month 65:3, pages 51-90.
Crossref
Peng-Yang Hsu, Hui-Ju Yang, Tao-Hsiang Yang & Che-Chun Su. (2018) 5-hydroxytryptophan attenuates imiquimod-induced psoriasiform dermatitis probably through inhibition of IL-17A production and keratinocyte activation. Experimental Dermatology 27:11, pages 1273-1279.
Crossref
Holm H. Uhlig & Fiona Powrie. (2018) Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease. Annual Review of Immunology 36:1, pages 755-781.
Crossref
K.A. Papp, C.L. LeonardiA. Blauvelt, K. Reich, N.J. KormanM. Ohtsuki, C. Paul, S. BallG.S. CameronJ. EricksonL. ZhangL. MallbrisC.E.M. Griffiths. (2018) Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3). British Journal of Dermatology 178:3, pages 674-681.
Crossref
M. Masson Regnault, M.‐P. Konstantinou, A. Khemis, Y. Poulin, M. Bourcier, F. Amelot, C. Bulaï Livideanu & C. Paul. (2017) Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients. Journal of the European Academy of Dermatology and Venereology 31:9, pages 1491-1496.
Crossref
Felipe Eduardo de Oliveira, Rodnei Dennis Rossoni, Patricia Pimentel de Barros, Barbara Evelyn Begnini, Juliana Campos Junqueira, Antonio Olavo Cardoso Jorge, Mariella Vieira Pereira Leão & Luciane Dias de Oliveira. (2017) Immunomodulatory effects and anti-Candida activity of lactobacilli in macrophages and in invertebrate model of Galleria mellonella. Microbial Pathogenesis 110, pages 603-611.
Crossref
Remy Robert, Caroline Ang, Guizhi Sun, Laurent Juglair, Ee X. Lim, Linda J. Mason, Natalie L. Payne, Claude C.A. Bernard & Charles R. Mackay. (2017) Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice. JCI Insight 2:15.
Crossref
D.M. Saunte, U. Mrowietz, L. Puig & C. Zachariae. (2017) Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management . British Journal of Dermatology 177:1, pages 47-62.
Crossref
C.E.M. Griffiths. (2017) Systems medicine and psoriasis. British Journal of Dermatology 176:3, pages 560-562.
Crossref
A. Egeberg, L. Mallbris, G. Gislason, P.R. Hansen & U. Mrowietz. (2017) Risk of periodontitis in patients with psoriasis and psoriatic arthritis. Journal of the European Academy of Dermatology and Venereology 31:2, pages 288-293.
Crossref
Melinda Liu, Yuan Yu M. Huang, Sylvia Hsu & Joseph S. Kass. (2016) Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications. CNS Drugs 30:12, pages 1149-1168.
Crossref
Jensen Yeung & Venus Valbuena. (2016) Successful use of secukinumab in pustular psoriasis. JAAD Case Reports 2:6, pages 470-472.
Crossref
Zenas Z. N. Yiu & Richard B. Warren. (2016) Novel Oral Therapies for Psoriasis and Psoriatic Arthritis. American Journal of Clinical Dermatology 17:3, pages 191-200.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.